Replies to post #208870 on Biotech Values

[DewDiligence]

Corrected†—1Q17 HCV/ GT1: Harvoni vs Viekira* vs Zepatier ($ M)

 
 Worldwide   
 Harvoni         1371  68.1%  
 Viekira          263  13.1%  
 Zepatier         378  18.8%  
 ========        ==== ======  
 Total           2012 100.0%  
    
 US 
 Harvoni          926  79.6%  
 Viekira           38   3.3%  
 Zepatier         200  17.2%  
 ========        ==== ======  
 Total           1164 100.0%  
    
 Ex-US 
 Harvoni          445  52.5%  
 Viekira          225  26.5%  
 Zepatier         178  21.0%  
 ========        ==== ======  
                  848 100.0%

*Includes Viekirax/Technivie (2-DAA) brands.

†h/t @JamesH_DRG.